China Diabetes Associated Ophthalmic Treatment Market Size & Outlook, 2028

Revenue, 2020 (US$M)

$1,628.9

Forecast, 2028 (US$M)

$2,815.3

CAGR, 2021 - 2028

7.1%

Report Coverage

China

China diabetes associated ophthalmic treatment market, 2017-2028 (US$M)

Related Markets

Global Diabetes Associated Ophthalmic Treatment Industry

North America Diabetes Associated Ophthalmic Treatment Market Outlook

U.S. Diabetes Associated Ophthalmic Treatment Market Outlook

Canada Diabetes Associated Ophthalmic Treatment Market Outlook

Europe Diabetes Associated Ophthalmic Treatment Market Outlook

Germany Diabetes Associated Ophthalmic Treatment Market Outlook

France Diabetes Associated Ophthalmic Treatment Market Outlook

Italy Diabetes Associated Ophthalmic Treatment Market Outlook

Spain Diabetes Associated Ophthalmic Treatment Market Outlook

UK Diabetes Associated Ophthalmic Treatment Market Outlook

Asia Pacific Diabetes Associated Ophthalmic Treatment Market Outlook

Japan Diabetes Associated Ophthalmic Treatment Market Outlook

India Diabetes Associated Ophthalmic Treatment Market Outlook

Australia Diabetes Associated Ophthalmic Treatment Market Outlook

South Korea Diabetes Associated Ophthalmic Treatment Market Outlook

Latin America Diabetes Associated Ophthalmic Treatment Market Outlook

Mexico Diabetes Associated Ophthalmic Treatment Market Outlook

Argentina Diabetes Associated Ophthalmic Treatment Market Outlook

Colombia Diabetes Associated Ophthalmic Treatment Market Outlook

Brazil Diabetes Associated Ophthalmic Treatment Market Outlook

MEA Diabetes Associated Ophthalmic Treatment Market Outlook

South Africa Diabetes Associated Ophthalmic Treatment Market Outlook

Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Outlook

UAE Diabetes Associated Ophthalmic Treatment Market Outlook

China diabetes associated ophthalmic treatment market highlights

The China diabetes associated ophthalmic treatment market generated a revenue of USD 1,628.9 million in 2020 and is expected to reach USD 2,815.3 million by 2028.
The China market is expected to grow at a CAGR of 7.1% from 2021 to 2028.
In terms of segment, diabetic retinopathy was the largest revenue generating application in 2020.
Uveitis is the most lucrative application segment registering the fastest growth during the forecast period.

Diabetes associated ophthalmic treatment market data book summary

Market revenue in 2020	USD 1,628.9 million
Market revenue in 2028	USD 2,815.3 million
Growth rate	7.1% (CAGR from 2020 to 2028)
Largest segment	Diabetic retinopathy
Fastest growing segment	Uveitis
Historical data	2017 - 2019
Base year	2020
Forecast period	2021 - 2028
Quantitative units	Revenue in USD million
Market segmentation	Dry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic-associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema, Other Application
Key market players worldwide	Alcon Inc, Johnson & Johnson, Bausch Health Companies Inc, Roche, Allergan, Bayer AG, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Pfizer Inc, Genentech, Carl Zeiss Meditec AG, Lumenis, Ellex, IRIDEX Corp, Topcon Corp, Abbott Laboratories, Quantel

Other key industry trends

In terms of revenue, China accounted for 6.0% of the global diabetes associated ophthalmic treatment market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
In Asia Pacific, South Korea diabetes associated ophthalmic treatment market is projected to lead the regional market in terms of revenue in 2028.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,063.2 million by 2028.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Diabetes Associated Ophthalmic Treatment Market Scope

Diabetes associated ophthalmic treatment market segmentation & scope

Diabetes Associated Ophthalmic Treatment Market Companies

Name	Profile	# Employees	HQ	Website

China diabetes associated ophthalmic treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes associated ophthalmic treatment market will help companies and investors design strategic landscapes.

Diabetic retinopathy was the largest segment with a revenue share of 25.91% in 2020. Horizon Databook has segmented the China diabetes associated ophthalmic treatment market based on dry eye syndrome, glaucoma, eye allergy & infection, diabetic retinopathy, diabetic-associated macular degeneration, uveitis, cataract, diabetic macular edema, other application covering the revenue growth of each sub-segment from 2017 to 2028.

China Diabetes Associated Ophthalmic Treatment Application Outlook (Revenue, USD Million, 2017-2028)
- Dry Eye Syndrome
- Glaucoma
- Eye Allergy & Infection
- Diabetic Retinopathy
- Diabetic-associated Macular Degeneration
- Uveitis
- Cataract
- Diabetic Macular Edema
- Other Application
China Diabetes Associated Ophthalmic Treatment Type Outlook (Revenue, USD Million, 2017-2028)
- Drugs
- Devices
China Diabetes Associated Ophthalmic Treatment End Use Outlook (Revenue, USD Million, 2017-2028)
- Hospitals
- Ophthalmic Centers
- Ambulatory Centers
- Others End Use

Reasons to subscribe to China diabetes associated ophthalmic treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China diabetes associated ophthalmic treatment market databook

Our clientele includes a mix of diabetes associated ophthalmic treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China diabetes associated ophthalmic treatment market, including forecasts for subscribers. This country databook contains high-level insights into China diabetes associated ophthalmic treatment market from 2017 to 2028, including revenue numbers, major trends, and company profiles.